» Articles » PMID: 36296374

G-Quadruplex Aptamer-Ligand Characterization

Overview
Journal Molecules
Publisher MDPI
Specialty Biology
Date 2022 Oct 27
PMID 36296374
Authors
Affiliations
Soon will be listed here.
Abstract

In this work we explore the structure of a G-rich DNA aptamer termed AT11-L2 (TGGTGGTGGTTGTTGTTGGTGGTGGTGGT; derivative of AT11) by evaluating the formation and stability of G-quadruplex (G4) conformation under different experimental conditions such as KCl concentration, temperature, and upon binding with a variety of G4 ligands (360A, BRACO-19, PDS, PhenDC3, TMPyP4). We also determined whether nucleolin (NCL) can be a target of AT11-L2 G4. Firstly, we assessed by circular dichroism, UV and NMR spectroscopies the formation of G4 by AT11-L2. We observed that, for KCl concentrations of 65 mM or less, AT11-L2 adopts hybrid or multiple topologies. In contrast, a parallel topology predominates for buffer containing 100 mM of KCl. The of AT11-L2 in 100 mM of KCl is 38.9 °C, proving the weak stability of this sequence. We also found that upon titration with two molar equivalents of 360A, BRACO-19 and PhenDC3, the G4 is strongly stabilized and its topology is maintained, while the addition of 3.5 molar equivalents of TMPyP4 promotes the disruption of G4. The values between AT11-L2 G4, ligands and NCL were obtained by fluorescence titrations and are in the range of µM for ligand complexes and nM when adding NCL. In silico studies suggest that four ligands bind to the AT11-L2 G4 structure by stacking interactions, while the RBD1,2 domains of NCL interact preferentially with the thymines of AT11-L2 G4. Finally, AT11-L2 G4 co-localized with NCL in NCL-positive tongue squamous cell carcinoma cell line.

Citing Articles

Selection, characterization, and biosensing applications of DNA aptamers targeting cyanotoxin BMAA.

Santiago-Maldonado X, Rodriguez-Martinez J, Lopez L, Cunci L, Bayro M, Nicolau E RSC Adv. 2024; 14(20):13787-13800.

PMID: 38681844 PMC: 11046380. DOI: 10.1039/d4ra02384f.


Aptamers for the Delivery of Plant-Based Compounds: A Review.

Gamboa J, Lourenco P, Cruz C, Gallardo E Pharmaceutics. 2024; 16(4).

PMID: 38675202 PMC: 11053555. DOI: 10.3390/pharmaceutics16040541.


Assessment of Aptamer as a Potential Drug Targeted Delivery for Retinal Angiogenesis Inhibition.

Moreira D, Lopes-Nunes J, Santos F, Campello M, Oliveira M, Paulo A Pharmaceuticals (Basel). 2023; 16(5).

PMID: 37242534 PMC: 10221175. DOI: 10.3390/ph16050751.

References
1.
Roxo C, Kotkowiak W, Pasternak A . G-Quadruplex-Forming Aptamers-Characteristics, Applications, and Perspectives. Molecules. 2019; 24(20). PMC: 6832456. DOI: 10.3390/molecules24203781. View

2.
Sun H, Zhu X, Lu P, Rosato R, Tan W, Zu Y . Oligonucleotide aptamers: new tools for targeted cancer therapy. Mol Ther Nucleic Acids. 2014; 3:e182. PMC: 4221593. DOI: 10.1038/mtna.2014.32. View

3.
Wu X, Zhao Z, Bai H, Fu T, Yang C, Hu X . DNA Aptamer Selected against Pancreatic Ductal Adenocarcinoma for in vivo Imaging and Clinical Tissue Recognition. Theranostics. 2015; 5(9):985-94. PMC: 4493536. DOI: 10.7150/thno.11938. View

4.
Santos T, Miranda A, Imbert L, Monchaud D, Salgado G, Cabrita E . Targeting a G-quadruplex from let-7e pre-miRNA with small molecules and nucleolin. J Pharm Biomed Anal. 2022; 215:114757. DOI: 10.1016/j.jpba.2022.114757. View

5.
Mergny J, Li J, Lacroix L, Amrane S, Chaires J . Thermal difference spectra: a specific signature for nucleic acid structures. Nucleic Acids Res. 2005; 33(16):e138. PMC: 1201377. DOI: 10.1093/nar/gni134. View